American Society of Clinical Oncology

SHERPA: White

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. O'Reilly
    O'Reilly
  4. Saltz
    Saltz
  5. Bajorin
    Bajorin
  6. Kris
    Kris
  7. Hudis
    Hudis
  8. Morris
    Morris
  9. Rosenberg
    Rosenberg
  10. Robson
    Robson

Groups

  1. Department of Medicine (6399)
  2. Solid Tumor Oncology Division (5537)
  3. Survivorship Research (1997)
  4. Genitourinary Oncology Service (1768)
  5. Surgery (1637)
  6. Epidemiology and Biostatistics (1495)
  7. GSK Faculty (1389)
  8. Population Sciences Research Program (1379)
  9. Gastrointestinal Oncology Service (1353)
  10. Hematologic Malignancies, Division of (1281)
Search Within
Formats
  1. Meeting Abstract (6334)
  2. Journal Article (2579)
  3. Editorial (76)
  4. Review (68)
  5. Guidelines (54)
  6. Correspondence (49)
  7. Miscellaneous (4)
  8. Conference Paper (3)
Groups
  1. Department of Medicine (6399)
  2. Solid Tumor Oncology Division (5537)
  3. Survivorship Research (1997)
  4. Genitourinary Oncology Service (1768)
  5. Surgery (1637)
  6. Epidemiology and Biostatistics (1495)

More Groups

People
  1. Robert Motzer (451)
  2. Howard Scher (334)
  3. Eileen O'Reilly (306)
  4. Leonard Saltz (283)
  5. Dean Bajorin (280)
  6. Mark Kris (253)

More People

Years
  1. 2025 (275)
  2. 2024 (554)
  3. 2023 (580)
  4. 2022 (554)
  5. 2021 (504)
  6. 2020 (539)

More Years

Publications
  1. Journal of Clinical Oncology (8694)
  2. JCO Precision Oncology (171)
  3. Journal of Oncology Practice (124)
  4. American Society of Clinical Oncology Educational Book (112)
  5. JCO Clinical Cancer Informatics (53)
  6. JCO Oncology Practice (7)

More Publications

Results (9167)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Alliance EAY191-A6: FOLFOX in combination with binimetinib as second-line therapy for patients with advanced biliary tract cancers (BTCs) with MAPK pathway alterations: A ComboMATCH treatment trial
    Meeting Abstract

    Shergill, A.; Liao, C. Y.; Elsaid, M. I.; Al Baghdadi, T.; Ji, Y.; Feldman, D.; George, S.; O'Reilly, E. M.; Meyerhardt, J. A.; Berg, S. A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A clinical-genetic (CG) circulating tumor DNA (ctDNA)-based prognostic model for predicting overall survival (OS) in men with metastatic castrate-resistant prostate cancer (mCRPC) treated with potent androgen receptor inhibition (Alliance)
    Meeting Abstract

    Halabi, S.; Luo, B.; Guo, S. S.; Knutson, T.; Lyman, J.; Kobilka, A.; Beltran, H.; Antonarakis, E. S.; Rosenberg, J. E.; Galsky, M. D.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Effect of multi-cancer early detection screening on late-stage cancers: A modeling study
    Meeting Abstract

    Chhatwal, J.; Xiao, J.; Merdan, S.; ElHabr, A.; Tyson, C.; Cao, X.; Raoof, S.; Fendrick, A. M.; Ozbay, B. B.; Limburg, P. J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Phase 1b study evaluating the efficacy and safety of ABBV-400, a c-Met-targeting antibody-drug conjugate, in select advanced solid tumor indications
    Meeting Abstract

    Perets, R.; Sharma, M.; Strickler, J. H.; Golan, T.; Hollebecque, A.; Henner, W.; Vasilopoulos, A.; Thiele, G. M.; Burns, M. C.; Harding, J. J.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase 2 trial of ADT interruption in patients responding exceptionally to AR-pathway inhibitor in metastatic hormone-sensitive prostate cancer (A-DREAM/Alliance A032101)
    Meeting Abstract

    Choudhury, A. D.; Heller, G.; Reimers, M. A.; Laccetti, A. L.; Smieliauskas, F.; Ravi, P.; Dooley, K.; Mazza, G. L.; Gartrell, B. A.; Steen, P. D.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Survivorship care plans and fear of recurrence in patients with breast cancer (BC)
    Meeting Abstract

    Weiss, M. C.; Chino, J. P.; Thom, B.; Meske, S.; Ganz, P. A.; Chino, F.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Safety of tabelecleucel with pembrolizumab in recurrent/metastatic Epstein-Barr virus-associated nasopharyngeal carcinoma
    Meeting Abstract

    Colevas, A. D.; Cohen, R. B.; Park, J. C.; Pfister, D. G.; Massarelli, E.; Li, Z.; Xing, B.; Dinavahi, R.; Mehta, A.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Radiation dose escalation and local control for intermediate-risk rhabdomyosarcoma on ARST1431: A report from the Children's Oncology Group
    Meeting Abstract

    Jackson, C.; Xue, W.; Gupta, A. A.; Qumseya, A.; Dasgupta, R.; Hill-Kayser, C. E.; Spalding, A.; Rodeberg, D. A.; Harrison, D. J.; Venkatramani, R.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Supplemental Nutrition Assistance Program (SNAP) policy changes and mammography use in the United States
    Meeting Abstract

    Kazmi, A.; Hussaini, S. M. Q.; Chino, F.; Yabroff, R.; Barnes, J. M.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • MagnetisMM-30: A phase 1b, open-label study of elranatamab in combination with iberdomide in patients with relapsed or refractory multiple myeloma (RRMM)
    Meeting Abstract

    Lesokhin, A. M.; Raza, M. S.; Acosta, J.; Muller, P.; O'Connell, A.; Yver, A.; Lou, C.; Finn, G.; Service, M.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save